CAMP4 Therapeutics Ownership | Who Owns CAMP4 Therapeutics?
CAMP4 Therapeutics Ownership Summary
CAMP4 Therapeutics is owned by 72.12% institutional investors, 9.65% insiders, and 18.23% retail investors. Janus henderson group is the largest institutional shareholder, holding 12.15% of CAMP shares. Fidelity Select Biotechnology is the top mutual fund, with 4.92% of its assets in CAMP4 Therapeutics shares.
CAMP Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | CAMP4 Therapeutics | 72.12% | 9.65% | 18.23% |
| Sector | Healthcare Stocks | 244.59% | 12.11% | -156.70% |
| Industry | Biotech Stocks | 379.61% | 11.70% | -291.31% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Janus henderson group | 6.31M | 12.15% | $27.88M |
| 5am venture management | 5.87M | 11.31% | $25.88M |
| Fmr | 4.93M | 9.51% | $21.76M |
| Vanguard group | 1.67M | 8.30% | $10.26M |
| Vivo capital | 4.25M | 8.18% | $18.73M |
| Balyasny asset management | 2.63M | 5.07% | $11.61M |
| Enavate sciences gp | 2.19M | 4.22% | $9.66M |
| Ah capital management | 2.13M | 4.09% | $9.37M |
| Adage capital partners gp | 1.96M | 3.78% | $8.65M |
| Stonepine capital management | 1.39M | 2.68% | $6.13M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| 5am venture management | 5.87M | 7.19% | $25.88M |
| Harbourvest partners | 1.27M | 5.56% | $5.61M |
| Enavate sciences gp | 2.19M | 2.75% | $9.66M |
| Stonepine capital management | 1.39M | 2.45% | $6.13M |
| Vivo capital | 4.25M | 1.56% | $18.73M |
| Ah capital management | 2.13M | 0.73% | $9.37M |
| Silverarc capital management | 653.59K | 0.29% | $2.88M |
| Summittx capital | 339.52K | 0.05% | $1.50M |
| Balyasny asset management | 2.63M | 0.02% | $11.61M |
| Janus henderson group | 6.31M | 0.01% | $27.88M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Vanguard group | 1.67M | 0.00% | 1.36M |
| Stonepine capital management | 1.39M | 2.45% | 1.16M |
| Silverarc capital management | 653.59K | 0.29% | 653.59K |
| Summittx capital | 339.52K | 0.05% | 339.52K |
| Balyasny asset management | 2.63M | 0.02% | 195.54K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Enavate sciences gp | 2.19M | 2.75% | -844.90K |
| Franklin resources | - | - | -635.05K |
| Susquehanna group, llp | - | - | -336.05K |
| Ecor1 capital | - | - | -325.00K |
| Adage capital partners gp | 1.96M | 0.01% | -220.90K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Summittx capital | 339.52K | 0.05% | 339.52K | $1.50M |
| Vanguard fiduciary trust | 195.01K | 0.00% | 195.01K | $860.01K |
| Hudson bay capital management lp | 48.51K | 0.00% | 48.51K | $213.93K |
| Charles schwab investment management | 20.00K | - | 20.00K | $88.20K |
| Vanguard global advisers | 11.62K | - | 11.62K | $51.22K |
Sold Out
| Holder | Change |
|---|---|
| Your advocates ltd., llp | -2.00 |
| Eversource wealth advisors | -3.00 |
| Sterling capital management | -71.00 |
| Nisa investment advisors | -101.00 |
| Wells fargo & company/mn | -119.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2026 | 62 | 31.91% | 41,777,586 | 5.01% | 72 | 1.53% | 39 | 30.00% | 12 | 33.33% |
| Mar 31, 2026 | 10 | -74.36% | 1,795,202 | -95.31% | 3 | 0.01% | 7 | -70.83% | 1 | -88.89% |
| Dec 31, 2025 | 21 | -25.00% | 7,426,078 | -73.68% | 36 | 0.19% | 15 | 15.38% | 4 | -50.00% |
| Sep 30, 2025 | 27 | 3.85% | 28,010,083 | 139.07% | 138 | 3.85% | 13 | - | 8 | -11.11% |
| Jun 30, 2025 | 28 | -26.32% | 11,744,552 | 20.46% | 60 | 8.68% | 14 | -22.22% | 10 | -9.09% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Fidelity Select Biotechnology | 2.55M | 4.92% | 1.23M |
| Vanguard Total Stock Mkt Idx Inv | 1.14M | 2.19% | - |
| Vanguard MStar Total Stk Mkt Idx Invest | 1.14M | 2.19% | - |
| Vanguard Morn Total Stk Mkt Idx Investor | 1.14M | 2.19% | - |
| Fidelity Growth Company Fund | 821.77K | 1.58% | 421.70K |
| Fidelity Growth Compy Commingled Pl S | 549.03K | 1.06% | - |
| iShares Russell 2000 ETF | 492.88K | 0.95% | -8.74K |
| Vanguard Institutional Extnd Mkt Idx Tr | 357.19K | 0.69% | - |
| iShares Russell 2000 Growth ETF | 289.90K | 0.56% | -2.65K |
| Fidelity Growth Company K6 | 235.16K | 0.45% | 125.65K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Aug 31, 2026 | Gold Kelly | Chief Financial Officer | Buy | $39.60K |
| Aug 27, 2026 | Schwab Andrew J. | - | Sell | $1.62M |
| Aug 24, 2026 | Schwab Andrew J. | - | Sell | $45.00 |
| Aug 19, 2026 | Schwab Andrew J. | - | Sell | $214.90K |
| Aug 20, 2026 | Schwab Andrew J. | - | Sell | $520.74K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q3 | 6 | 6 |
| 2026 Q2 | - | - |
| 2025 Q4 | - | - |
| 2025 Q3 | 9 | - |
| 2025 Q2 | - | - |
CAMP Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools